BeyondSpring Inc.
BeyondSpring Inc. (BYSI) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · BYSI · as of Sep 30, 2025
Ownership Breakdown
23
Institutional Holders
▲ 3 vs Q2
$10.72M
Total Inst. Value
▼ $3.39M vs Q2
41.12M
Shares Outstanding
freeFloat 77.07%
5.92M
13F Shares Held
▼ 82,466 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
BYSI largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
DECHENG CAPITAL LLC pharmaceutical preparations | 4.29M | 10.63% | 10.63% | $7.76B | Nov 14, 2025 | ▼ 245.4K |
BLACKROCK, INC. pharmaceutical preparations | 639.7K | 1.59% | 1.59% | $1.16B | Nov 12, 2025 | ▲ 4.6K |
VANGUARD GROUP INC pharmaceutical preparations | 546.7K | 1.36% | 1.36% | $989.52M | Nov 7, 2025 | ▲ 23.0K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 315.5K | 78.25% | 78.25% | $571.38M | Nov 12, 2025 | ▲ 59.3K |
WELLS FARGO & COMPANY/MN pharmaceutical preparations | 175.0K | 43.41% | 43.41% | $316.75M | Nov 13, 2025 | — held |
NORTHERN TRUST CORP pharmaceutical preparations | 70.8K | 17.56% | 17.56% | $128.11M | Nov 14, 2025 | ▲ 54.5K |
JANE STREET GROUP, LLC pharmaceutical preparations | 39.0K | 9.67% | 9.67% | $70.59M | Nov 14, 2025 | ▼ 1.1K |
SUSQUEHANNA INTERNATIONAL GROUP, LLP pharmaceutical preparations | 31.5K | 7.81% | 7.81% | $57.02M | Nov 14, 2025 | ▼ 10.6K |
TANAKA CAPITAL MANAGEMENT INC pharmaceutical preparations | 26.3K | 6.52% | 6.52% | $48.00M | Nov 14, 2025 | NEW |
CITADEL ADVISORS LLC pharmaceutical preparations | 24.5K | 6.08% | 6.08% | $44.34M | Nov 14, 2025 | ▼ 6.5K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
7
Increased
+142.6K shares2
New Positions
first time holders7
Decreased
−269.7K shares0
Sold Out
fully exitedNet shares change (top 50)
127.1K
+142.6K / −269.7K
Net new holders
+2
2 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
BYSI insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
6
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Huang Lan Chief Executive Officer | Mar 20, 2026 | Gift | 260,582 | — | — | 0 | Form 4 ↗ |
Kirkby Matthew director | Apr 1, 2026 | Award | 23,902 | $1.64 | $39.2K | 23.9K | Form 4 ↗ |
Fabbio Patrick director | Apr 1, 2026 | Award | 22,165 | $1.64 | $36.4K | 22.2K | Form 4 ↗ |
Delaney Brendan director | Apr 1, 2026 | Award | 20,427 | $1.64 | $33.5K | 20.4K | Form 4 ↗ |
Majeti Jiangwen director | Apr 1, 2026 | Award | 21,730 | $1.64 | $35.6K | 21.7K | Form 4 ↗ |
Lu Yingjuan June Chief Scientific Officer | Apr 1, 2026 | Award | 17,840 | $1.64 | $29.3K | 17.8K | Form 4 ↗ |
Huang Lan Chief Executive Officer | Apr 1, 2026 | Award | 11,514 | $1.80 | $20.8K | 11.5K | Form 4 ↗ |
Xu Sihai director | Apr 1, 2026 | Award | 18,689 | $1.64 | $30.6K | 18.7K | Form 4 ↗ |
Decheng Capital China Life Sciences USD Fund III, L.P. 10 percent owner | Oct 16, 2025 | Sale | 85,798 | $1.72 | $147.6K | 1.56M | Form 4 ↗ |
Decheng Capital China Life Sciences USD Fund III, L.P. 10 percent owner | Oct 17, 2025 | Sale | 45,513 | $1.76 | $80.1K | 1.52M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
BeyondSpring Inc. (BYSI) is primarily owned by institutional investors, who hold approximately 14.4% of total shares outstanding. Company insiders own approximately 22.93%, while retail and public investors account for the remaining 62.67%.
The largest institutional shareholder of BeyondSpring Inc. is DECHENG CAPITAL LLC, holding approximately 4.29 million shares — equal to 10.63% of outstanding shares — as of September 30, 2025.
A total of 23 institutional investors currently hold BYSI stock, with a combined institutional value of approximately $10,717,375 as of the most recent 13F filing period.
Frequently asked questions
BYSI ownershipBeyondSpring Inc. (BYSI) is primarily owned by institutional investors, who hold approximately 14.4% of shares. The largest shareholder is DECHENG CAPITAL LLC with a 10.63% stake. Company insiders hold 22.93%. Data sourced from SEC Form 13F as of September 30, 2025.